Trial no.:
|
PACTR201603000964133 |
Date of Approval:
|
08/12/2014 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Comparison of Haemodynamic Effects of Propofol and Two Different Concentrations of Propofol-Ketamine Admixture: A Randomised Control Trial |
Official scientific title |
Comparison of Haemodynamic Effects of Propofol and Two Different Concentrations of Propofol-Ketamine Admixture: A Randomised Control Trial |
Brief summary describing the background
and objectives of the trial
|
Statement of Problem
Propofol has become the most popular IV induction agent. However it commonly causes a significant drop in BP and has been associated with bradycardia. This is undesirable and limits its safe use in the critically ill and in those with limited physiological reserve. Induction with ketamine on the other hand is associated with an increase in both BP and pulse via stimulation of the sympathetic nervous system. These properties are desirable in a hypovolemia patient who still has a sympathetic reserve. However they limit the use of ketamine in those who have hypertension or ischaemic heart disease.
Since the development of an ideal intravenous induction agent is not yet achieved, can a combination of existing ones, specifically propofol and ketamine give rise to an agent with better a haemodynamic risk profile, less contraindications and improved patient and caregiver satisfaction? It is also not yet established which ratio of propofol to ketamine would provide the best cardiovascular stability as an induction agent.
Hypothesis
The aim of this prospective, randomized, case control clinical study is to evaluate:
1. The hypothesis that propofol- ketamine induction prevents a greater than 20 % drop in blood pressure better than propofol alone at induction of anaesthesia.
Objectives
The main objectives of the research are:
1. To evaluate if ketofol has better a haemodynamic profile as an induction agent than propofol alone.
2. To evaluate how two different ratios of the ketamine propofol admixture behave. In other words how much ketamine is necessary to counterbalance the negative chronotropic and inotropic effect of propofol alone?
|
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
,Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
02/06/2014 |
Actual trial start date |
06/08/2014 |
Anticipated date of last follow up |
27/02/2015 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
120 |
Actual target sample size (number of participants) |
120 |
Recruitment status |
Recruiting |
Publication URL |
|
|